Domestic bonds: MGI Pharma, 0% 2mar2024, USD (7121D) (US552880AB28)

Name: Domestic bonds: MGI Pharma, 0% 2mar2024, USD (7121D) (US552880AB28)
Creator: Cbonds
License: https://creativecommons.org/licenses/by/4.0/

Download

Copy issue information to clipboard

Copy to clipboard

Data copied to the clipboard

PDF download

Choose all Reset all

Download Cancel

Convertible, Trace-eligible, Senior Subordinated Unsecured

Status

Early redeemed

Amount

348,000,000 USD

Placement

***

Early redemption

*** (-)

ACI on

Country of risk

USA

Current coupon

Price

Yield / Duration

Calculate in two clicks! yield, duration and other parameters

Calculator

What is a calculator?

Placement amount

348,000,000 USD
Face value

1,000 USD
ISIN

US552880AB28
CFI

DCFUGR
FIGI

BBG000934HG4
Ticker

EISAI 1.6821 03/02/24

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way

Bond Search

Watchlist

Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Files

Prospectus

Prospectus

Authorization required

It is only possible to download bond prospectuses for paid Premium subscription access

Trading chart

Stock exchange selection

More about Cbonds Estimation

Bond is not traded; the issue is redeemed

Data display in a chart | table

Work with the chart: switching the price, period, issue comparison

Customize fields in the table

Found:

Show all fields

from

ADD-IN
Cbonds add-in API
bond data api

Authorization required

You need to request access

* Data is not available within the selected subscription

Quotes from market participants are indicative

Stock exchange and OTC quotes

Quotes provided by information providers are indicative in nature

Issue information

Profile

MGI Pharma, Inc., a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products for oncology and acute care applications. The company markets Aloxi (palonosetron hydrochloride) Injection, Dacogen (decitabine) for Injection, and Gliadel Wafer (polifeprosan 20 with carmustine implant) in the United States. The Company directly markets its products in the U.S. and collaborates with partners to reach international markets. The company was formerly known as Molecular Genetics, Inc. and changed its name to MGI Pharma, Inc. in January, 1990. The company was founded in 1979 and is headquartered in Bloomington, Minnesota. It has facilities in Bloomington, Minnesota; Lexington, Massachusetts; and Baltimore, Maryland. As of January 25, 2008, MGI Pharma, Inc. operates as a subsidiary of Eisai Corporation of North America, Inc.

Show more Hide

Issuer

Go to the issuer page
MGI Pharma
Full borrower / issuer name

MGI Pharma
Sector

Corporate
Industry

Miscellaneous Healthcare: Products and Services

Volume

Placement amount

348,000,000 USD

Face value

Face value

1,000 USD
Outstanding face value

*** USD
Increment

*** USD

Cash flow parameters

Reference rate

***

Coupon Rate

***

Day count convention

***

Interest Accrual Date

***

Coupon frequency

*** time(s) per year
Payment currency

***
Maturity date

***
Early redemption date

***

Cash flow

Export to Excel

Early redemption terms

***